Developing point-of-care technologies for early cancer detection
Technology Core
This study is working on creating easy-to-use and affordable cancer tests that can be done in local healthcare settings, especially for communities that need them the most, so everyone can get the early detection they deserve.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rice University NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10928780 on NIH RePORTER |
What this research studies
This research focuses on advancing point-of-care (POC) testing technologies specifically for cancer screening and early detection, particularly in underserved populations. It aims to identify and support innovative projects that can create high-performance, affordable tests that can be used in decentralized healthcare settings. By leveraging the successes of COVID-19 testing, the research seeks to overcome existing barriers to effective cancer detection and improve access to essential diagnostics. The approach involves collaboration with various stakeholders to ensure that these technologies are both effective and equitable.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from underserved populations who may have limited access to traditional cancer screening methods.
Not a fit: Patients who are already receiving regular and comprehensive cancer screening may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and effective cancer screening methods, improving early detection rates and outcomes for patients.
How similar studies have performed: Previous research has shown success in developing point-of-care testing technologies for infectious diseases, suggesting a promising potential for similar advancements in cancer detection.
Where this research is happening
Houston, United States
- Rice University — Houston, United States (Active)
Researchers
- Principal investigator: Richards-Kortum, Rebecca R. — Rice University
- Study coordinator: Richards-Kortum, Rebecca R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.